1. Home
  2. KYTX vs PBHC Comparison

KYTX vs PBHC Comparison

Compare KYTX & PBHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KYTX
  • PBHC
  • Stock Information
  • Founded
  • KYTX 2018
  • PBHC 1859
  • Country
  • KYTX United States
  • PBHC United States
  • Employees
  • KYTX N/A
  • PBHC N/A
  • Industry
  • KYTX
  • PBHC Major Banks
  • Sector
  • KYTX
  • PBHC Finance
  • Exchange
  • KYTX NYSE
  • PBHC Nasdaq
  • Market Cap
  • KYTX 92.1M
  • PBHC 92.1M
  • IPO Year
  • KYTX 2024
  • PBHC N/A
  • Fundamental
  • Price
  • KYTX $3.07
  • PBHC $14.61
  • Analyst Decision
  • KYTX Strong Buy
  • PBHC
  • Analyst Count
  • KYTX 5
  • PBHC 0
  • Target Price
  • KYTX $19.00
  • PBHC N/A
  • AVG Volume (30 Days)
  • KYTX 415.4K
  • PBHC 7.0K
  • Earning Date
  • KYTX 08-11-2025
  • PBHC 07-28-2025
  • Dividend Yield
  • KYTX N/A
  • PBHC 2.74%
  • EPS Growth
  • KYTX N/A
  • PBHC N/A
  • EPS
  • KYTX N/A
  • PBHC 0.53
  • Revenue
  • KYTX N/A
  • PBHC $41,317,000.00
  • Revenue This Year
  • KYTX N/A
  • PBHC N/A
  • Revenue Next Year
  • KYTX N/A
  • PBHC N/A
  • P/E Ratio
  • KYTX N/A
  • PBHC $27.73
  • Revenue Growth
  • KYTX N/A
  • PBHC 1.46
  • 52 Week Low
  • KYTX $1.78
  • PBHC $12.30
  • 52 Week High
  • KYTX $11.40
  • PBHC $19.86
  • Technical
  • Relative Strength Index (RSI)
  • KYTX 55.92
  • PBHC 41.32
  • Support Level
  • KYTX $2.86
  • PBHC $14.81
  • Resistance Level
  • KYTX $2.82
  • PBHC $15.95
  • Average True Range (ATR)
  • KYTX 0.31
  • PBHC 0.27
  • MACD
  • KYTX -0.03
  • PBHC -0.06
  • Stochastic Oscillator
  • KYTX 40.94
  • PBHC 0.00

About KYTX KYVERNA THERAPEUTICS INC

Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product, KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.

About PBHC Pathfinder Bancorp Inc. (MD)

Pathfinder Bancorp Inc is a holding company for Pathfinder Bank. The Pathfinder Bank is a commercial bank engaged in attracting deposits from the general public and investing such deposits, together with other sources of funds, in loans secured by residential real estate, commercial real estate, small business loans, and consumer loans. The bank invests a portion of its assets in debt securities issued by the United States Government and its agencies and sponsored enterprises, state and municipal obligations, corporate debt securities, mutual funds, and equity securities. The principal source of income is interest on loans and investment securities.

Share on Social Networks: